Esperion Therapeutics
ESPR
$1.92
Share price
-3.27%
Change (1 day)
60.42%
Change (1 year)
Categories
Earnings for Esperion Therapeutics (ESPR)
Earnings in 2023 (TTM): -$0.16 B
According to Esperion Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.16 B. an increase over its 2022 earnings that were of -$0.18 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Esperion Therapeutics from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | -$0.16 B | -15.03% |
| 2022 | -$0.18 B | -20.61% |
| 2021 | -$0.23 B | 84.28% |
| 2020 | -$0.13 B | 35.75% |
| 2019 | -$89.05 M | -55.71% |
| 2018 | -$0.21 B | 19.57% |
| 2017 | -$0.17 B | 125.39% |
| 2016 | -$74.61 M | 51.43% |
| 2015 | -$49.27 M | 36.45% |
| 2014 | -$36.11 M | 43.55% |
| 2013 | -$25.16 M | 145.26% |
| 2012 | -$10.26 M | |
| 2002 | -$29.24 M | -7.81% |
| 2001 | -$31.72 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $3.26 B | -2,274.06% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $4.19 B | -2,894.47% | 🇺🇸 USA |
 Ultragenyx RARE | -$0.55 B | 260.99% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | -$0.18 B | 17.87% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | -$0.16 B | -0.11% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.18 B | -225.48% | 🇺🇸 USA |